Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLL.L Regulatory News (CLL)

  • There is currently no data for CLL

Director/PDMR Shareholding

27 Sep 2017 16:59

RNS Number : 0162S
Cello Group plc
27 September 2017
 

27 September 2017

Cello Group plc

 ("Cello" or the "Company")

 

Director/PDMR Shareholding

 

The Company has been notified that on 27 September 2017 Mark Bentley, Group Finance Director, sold and then re-purchased 110,000 ordinary shares of 10 pence each in the Company ("Ordinary Shares"), in order to transfer the Ordinary Shares to Mr Bentley's SIPP. The sale price was 127.50 pence per share and the purchase price was 127.53 pence per share.

The sale and purchase has no effect on the total number of Ordinary Shares held by Mr Bentley and, following this transaction, Mr Bentley remains beneficially and non-beneficially interested in 442,518 Ordinary Shares, representing approximately 0.4 per cent. of the Company's issued ordinary share capital.

The Company has also received notification that on 27 September 2017, Jane Shirley, a director of Cello Health, exercised share options over 20,000 Ordinary Shares for an exercise price of 10 pence per share, and subsequently sold the 20,000 Ordinary Shares for a price of 127 pence per share. In addition, on 26 September 2017, Alistair Shirley, a person closely associated with Jane Shirley, sold 421 Ordinary Shares at a price of 129 pence per share.

Following the above transactions, Jane Shirley and her persons closely associated hold 78,000 Ordinary Shares, representing approximately 0.1% of the Company's issued ordinary share capital.

 

Enquiries:

 

Cello Group

020 7812 8460

Mark Scott, Chief Executive

Mark Bentley, Finance Director

Cenkos Securities

0207 397 8900

Bobbie Hilliam

Harry Hargreaves

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Mark Bentley

2

Reason for the notification

a)

Position/status

Finance Director

b)

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Cello Group plc

b)

LEI

2138004TZYGZLWQP7N64

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of 10p each

 

 

GB00B0310763

b)

Nature of the transaction

Sale of Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

127.50p

110,000

d)

Aggregated information

 

-Aggregated volume

 

-Price

 

 

110,000

 

£140,250

e)

Date of the transaction

27 September 2017

f)

Place of the transaction

XLON

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Mark Bentley

2

Reason for the notification

a)

Position/status

Finance Director

b)

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Cello Group plc

b)

LEI

2138004TZYGZLWQP7N64

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of 10p each

 

 

GB00B0310763

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

127.53p

110,000

d)

Aggregated information

 

-Aggregated volume

 

-Price

 

 

110,000

 

£140,283

e)

Date of the transaction

27 September 2017

f)

Place of the transaction

XLON

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Jane Shirley

2

Reason for the notification

a)

Position/status

Director of Cello Health

b)

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Cello Group plc

b)

LEI

2138004TZYGZLWQP7N64

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of 10p each

 

 

GB00B0310763

b)

Nature of the transaction

Exercise of options over Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

10p

20,000

d)

Aggregated information

 

-Aggregated volume

 

-Price

 

 

20,000

 

£2,000

e)

Date of the transaction

27 September 2017

f)

Place of the transaction

Outside trading venue

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Jane Shirley

2

Reason for the notification

a)

Position/status

Director of Cello Health

b)

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Cello Group plc

b)

LEI

2138004TZYGZLWQP7N64

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of 10p each

 

 

GB00B0310763

b)

Nature of the transaction

Sale of Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

127p

20,000

d)

Aggregated information

 

-Aggregated volume

 

-Price

 

 

20,000

 

£25,400

e)

Date of the transaction

27 September 2017

f)

Place of the transaction

XLON

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Alistair Shirley

2

Reason for the notification

a)

Position/status

Person closely associated with Jane Shirley

b)

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Cello Group plc

b)

LEI

2138004TZYGZLWQP7N64

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of 10p each

 

 

GB00B0310763

b)

Nature of the transaction

Sale of Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

129p

421

d)

Aggregated information

 

-Aggregated volume

 

-Price

 

 

421

 

£543.09

e)

Date of the transaction

26 September 2017

f)

Place of the transaction

XLON

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHUBVVRBWAKUAR
Date   Source Headline
2nd Oct 20198:40 amRNSDisposal
18th Sep 20197:00 amRNSInterim Results
23rd Aug 201910:40 amRNSHolding(s) in Company
16th Aug 20197:00 amRNSAcquisition of ISS
6th Aug 20193:07 pmRNSTotal Voting Rights
6th Aug 20197:00 amRNSNotification of Half Year Results
18th Jul 20197:00 amRNSPre-close Trading Update
20th Jun 20194:29 pmRNSDirector/PDMR Shareholding
10th Jun 20199:41 amRNSTotal Voting Rights
24th May 201912:45 pmRNSBlock listing Interim Review
20th May 20194:29 pmRNSIssue of Equity
15th May 20197:00 amRNSHolding(s) in Company
8th May 20191:30 pmRNSResult of AGM
8th May 20197:00 amRNSAGM Statement
1st May 201912:15 pmRNSTotal Voting Rights
15th Apr 201911:12 amRNSAnnual Report and Notice of AGM
10th Apr 20197:00 amRNSCapital Markets Event
4th Apr 201910:00 amRNSTotal Voting Rights
27th Mar 20191:00 pmRNSHolding(s) in Company
21st Mar 20193:10 pmRNSDirector/PDMR Shareholding
21st Mar 20197:00 amRNSPreliminary Results
6th Mar 20191:51 pmRNSHolding(s) in Company
7th Feb 20197:00 amRNSNotice of Full Year Results
17th Jan 20197:00 amRNSPre-Close Trading Statement
14th Dec 20189:24 amRNSBlock Listing Update
23rd Nov 20183:45 pmRNSHolding(s) in Company
19th Nov 20182:45 pmRNSHolding(s) in Company
12th Nov 201811:30 amRNSDirectorate Change
5th Nov 20182:00 pmRNSDirectorate Change
31st Oct 20183:30 pmRNSDirector/PDMR Shareholding
10th Oct 20187:00 amRNSDirector/PDMR Shareholding
2nd Oct 20187:00 amRNSAppointment of Executive Director
25th Sep 20181:00 pmRNSDirector/PDMR Shareholding
25th Sep 20187:00 amRNSDirector/PDMR Shareholding
24th Sep 201811:39 amRNSTransfer of FTSE classification to Healthcare
21st Sep 201810:15 amRNSDirector/PDMR Shareholding
20th Sep 20184:00 pmRNSHolding(s) in Company
20th Sep 20187:00 amRNSDirector/PDMR Shareholding
19th Sep 20187:00 amRNSInterim Results
22nd Aug 20181:51 pmRNSHolding(s) in Company
17th Aug 20187:00 amRNSNotification of Half Year Results
16th Aug 20182:00 pmRNSTotal Voting Rights
16th Aug 20181:30 pmRNSBoard Changes
23rd Jul 20187:00 amRNSHolding(s) in Company
19th Jul 20187:00 amRNSPre-close Trading Update
17th Jul 20187:00 amRNSChange of registered office
4th Jul 20181:53 pmRNSHolding(s) in Company
27th Jun 201812:46 pmRNSHolding(s) in Company
22nd Jun 20184:47 pmRNSHolding(s) in Company
20th Jun 20182:25 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.